Contributed By: <\/p>\n
Michelle Leis <\/p>\n
OPB | Jan. 12, 2015 12:06 p.m. | Updated: Jan. 12, 2015 1:41 p.m. <\/p>\n
In 2003, the first human genome wassequenced through the collaborative effort of 20 research centers. It cost nearly $3billion. <\/p>\n
Almost 12 years later, the cost ofsequencing has come down faster than Moores law. We can now sequence an entire genome for $2,000 to $3,ooo in a fraction of the time it took to sequence that first humangenome. <\/p>\n
In the first part of a new series on genomics, we examine the ways in which genetic data is used to personalize medicine, and take a look at whats being done in the clinical setting. Specifically, well address how this technology has changedwhat we know about cancer and discuss some of the limitations of what we can accomplish through genomeanalysis. <\/p>\n
GUESTS: <\/p>\n
In the next part of our series, well look into some of the legal and ethical concerns surrounding geneticresearch. <\/p>\n
Rose E. Tucker Charitable Trust <\/p>\n
James F. and Marion L. Miller Foundation <\/p>\n
<\/p>\n
View original post here: Contributed By: Michelle Leis OPB | Jan. 12, 2015 12:06 p.m. Continue reading
\nGenomics: The Slow Revolution<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"